Osimertinib No Longer Available Phase N/A Trials for EGFR T790M Mutation Positive NSCLC

IndicationsStatusPurposePhase
No Longer AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02451852AZD9291 US Expanded Access Program